文献速递类风湿关节炎

IgM型抗乙酰化蛋白抗体与B细胞在类风湿关节炎抗修饰蛋白自身免疫起源中的作用

The Role of IgM Anti-acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2026-06-22

该研究探讨IgM型抗乙酰化蛋白抗体(AAPA IgM)是否作为类风湿关节炎(RA)其他抗修饰蛋白抗体(AMPAs)的前体。纵向检测显示RA发病前AAPA IgM阳性率(27.3%)高于ACPA IgM(11.7%),但随疾病临近ACPA IgM升至51.2%而AAPA IgM稳定,且AAPA IgM阴性者亦可发生AMPAs。B细胞测序发现AAPA与ACPA表达B细胞均存在胚系编码BCR,提示AMPA反应存在多个起始点。

要点

  • RA发病前AAPA IgM阳性率高于ACPA IgM,但AAPA IgM不随疾病临近而升高。
  • AAPA IgM阴性个体仍可发生其他AMPAs,提示AAPA IgM非唯一前体。
  • AAPA与ACPA表达B细胞均可携带胚系编码BCR,支持多起点假说。

核心结论

  • RA中的AMPA反应并非单纯起源于AAPA IgM,发病前AMPA IgM阳性与后续AMPA演变缺乏关联。
  • AAPA与ACPA表达B细胞均存在胚系编码BCR,提示AMPA反应可能有多个起始点。

研究设计与样本

  • 测量脐血及3岁以内儿童血清AAPA IgM以评估其是否为天然自身抗体。
  • 纵向检测RA发病前个体AAPA与ACPA IgM水平。
  • 对AAPA与ACPA表达B细胞进行单细胞分选和测序分析BCR特征。

主要发现

  • AAPA IgM在生命早期未检测到。
  • RA发病前AAPA IgM阳性者为27.3%,ACPA IgM阳性者为11.7%。
  • 临近疾病发生时ACPA IgM阳性率升至51.2%,而AAPA IgM阳性率保持稳定。
  • AAPA IgM阴性个体中仍可发生AMPAs。
  • RA患者AAPA与ACPA表达B细胞中均鉴定出胚系编码BCR。

临床怎么用

  • AAPA IgM不宜单独作为RA早期AMPA演变的预测标志。
  • 评估RA自身免疫起源需考虑多种AMPA及B细胞胚系BCR特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rheumatoid arthritis (RA) is characterized by anti-modified protein antibodies (AMPAs), including anti-citrullinated protein antibodies (ACPA), anti-carbamylated protein antibodies (anti-CarP), and anti-acetylated protein antibodies (AAPA). In contrast to other AMPAs, AAPA IgM is found in healthy individuals, raising questions about its role in early immune responses. We investigated whether AAPA IgM serves as a precursor for other AMPAs, marking the initial breach of tolerance in RA. METHODS: AAPA IgM levels were measured in cord blood and serum of children up to three years old to assess whether it represents a natural (auto)antibody. To evaluate whether AAPA IgM presence precedes other AMPAs, we longitudinally measured AAPA and ACPA IgM in individuals before RA onset. To assess whether AAPA IgM-expressing B cells display a naive phenotype and carry germline-encoded B cell receptors (BCRs), single cells were sorted and sequenced. RESULTS: AAPA IgM was not detected in early life, but before RA onset, significantly more individuals were AAPA IgM positive (27.3%) compared to ACPA IgM positive (11.7%). Toward disease onset, ACPA IgM positivity increased to 51.2%, whereas AAPA IgM positivity remained stable. Furthermore, AMPAs developed in individuals who were AAPA IgM negative. Regarding B cell characteristics, germline-encoded BCRs were identified among both AAPA- and ACPA-expressing B cells in patients with RA. CONCLUSION: AMPA responses in RA do not appear to arise solely from AAPA IgM, as suggested by the lack of association between predisease AMPA IgM positivity and later AMPA evolution. This is further supported by the presence of germline-configured ACPA BCRs, suggesting multiple possible starting points for AMPA responses.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Athanasiadou A, Kroos S, van de Wetering R, et al. The Role of IgM Anti-acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis. Arthritis Rheumatol. 2026. PMID: 42328895. doi:10.1002/art.70259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。